Figure 1.
Plasma soluble receptor for advanced glycation end products (sRAGE) levels in patients with acute respiratory distress syndrome (ARDS), ventilated controls and healthy controls. Data are presented as means ± SEM (*P < 0.05).
Plasma soluble receptor for advanced glycation end products (sRAGE) levels in patients with acute respiratory distress syndrome (ARDS), ventilated controls and healthy controls. Data are presented as means ± SEM (*P < 0.05).